Asthma Clinical Trial
Official title:
Improving Parent Understanding of Instructions About Asthma Care
| NCT number | NCT01405625 |
| Other study ID # | 09-0358 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | July 2011 |
| Est. completion date | March 2018 |
| Verified date | October 2018 |
| Source | New York University School of Medicine |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Asthma has an especially great impact on poor urban children and their families. In addition
to higher asthma prevalence and morbidity, those in low SES urban areas are at risk for low
health literacy. Low health literacy is associated with poorer asthma outcomes. The provision
of a written asthma action plan has been shown to help with asthma management and to reduce
hospitalizations and ER visits. Poor urban families who may have low literacy may need an
alternative asthma action plan to convey the treatment plan.
This pilot study proposes to investigate whether a plain language asthma action plan can
improve parent understanding and adherence with medication instructions, compared to standard
written materials, among parents of children with asthma. This is an RCT in which parents of
children with asthma will be randomized to either receive a pictogram-based low literacy
asthma action plan, or a standard action plan (AAAAI), to examine whether those who receive
the low literacy plan have improved asthma action plan knowledge when presented with a
hypothetical scenario.
A second part of the study is to examine whether providers who are given the pictogram-based
low literacy asthma action plan will be more likely to counsel about certain aspects of
asthma management (eg. need for daily medications even when sick, spacer use, confusion
between everyday and rescue inhaler)compared to providers who receive use a standard action
plan (AAAAI). This is an RCT in which pediatric providers are randomized to counsel a
hypothetical patient using the pictogram-based action plan or the standard action plan
(AAAAI).
| Status | Completed |
| Enrollment | 449 |
| Est. completion date | March 2018 |
| Est. primary completion date | March 2018 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Parent study: Inclusion Criteria: - Primary caregiver / parent / legal guardian of child 2-12 years old - Child with diagnosis of asthma Exclusion Criteria: - Parent not English or Spanish-speaking Provider study: Inclusion Criteria: - Health providers who care for children with asthma |
| Country | Name | City | State |
|---|---|---|---|
| United States | NYU School of Medicine | New York | New York |
| Lead Sponsor | Collaborator |
|---|---|
| New York University School of Medicine | Feinberg School of Medicine, Northwestern University |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Asthma Action Plan knowledge (parent) | Outcome measure will be assessed on the day of enrollment only, using a hypothetical scenario. No outcome assessments will be performed after the day of enrollment. | 1 day (on same day of enrollment; no outcome assessment after day of enrollment) | |
| Secondary | Asthma action plan content (provider) | Provider coverage of green/yellow/red zone concepts, spacer use, medication information, symptoms; use of low literacy principles | same day as presentation of hypothetical counseling scenario |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|